Alkermes (ALKS) Net Cash Flow (2010 - 2026)
Alkermes' (ALKS) quarterly Net Cash Flow came in at $160.0 million in Q2 2026, up 31.78% year-over-year from $121.4 million in Q2 2025, and up 120.82% quarter-over-quarter from -$768.2 million in Q1 2026.
Analysis
Alkermes (ALKS) Net Cash Flow (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Net Cash Flow for 17 consecutive years, with $160.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Cash Flow rose 31.78% year-over-year to $160.0 million in Q2 2026; TTM through Jun 2026 was -$9.7 million, a 30.69% increase from a year earlier, with the FY2025 full-year figure at $828.6 million, up 598.21% from the prior year.
- Net Cash Flow was $160.0 million for Q2 2026 at Alkermes, up from -$768.2 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $503.3 million in Q4 2025 and troughed at -$768.2 million in Q1 2026.
- A 5-year average of $9.7 million and a median of $18.9 million in 2022 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow jumped 1333.9% in 2023 and sank 807.0% in 2026, its largest moves.
- Over 5 years, Net Cash Flow stood at $28.5 million in 2022, then sank by 767.14% to -$190.2 million in 2023, then surged by 44.73% to -$105.1 million in 2024, then jumped by 578.69% to $503.3 million in 2025, then sank by 68.22% to $160.0 million in 2026.
- The last three Net Cash Flow figures came in at $160.0 million (Q2 2026), -$768.2 million (Q1 2026), and $503.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -722.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 918.27 Mn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 374.50 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 521.33 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 523.50 Mn |
| 10 | Alkermes | 7.58 Bn | 6.92 Bn | 397.90 Mn | 159.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 159.98 Mn |
| Mar 31, 2026 | -768.22 Mn |
| Dec 31, 2025 | 503.33 Mn |
| Sep 30, 2025 | 95.25 Mn |
| Jun 30, 2025 | 121.39 Mn |
| Mar 31, 2025 | 108.66 Mn |
| Dec 31, 2024 | -105.15 Mn |
| Sep 30, 2024 | -138.86 Mn |
| Jun 30, 2024 | 114.40 Mn |
| Mar 31, 2024 | -36.72 Mn |
| Dec 31, 2023 | -190.24 Mn |
| Sep 30, 2023 | -18.08 Mn |
| Jun 30, 2023 | 344.39 Mn |
| Mar 31, 2023 | 28.93 Mn |
| Dec 31, 2022 | 28.52 Mn |
| Sep 30, 2022 | 9.31 Mn |
| Jun 30, 2022 | -27.91 Mn |
| Mar 31, 2022 | -54.99 Mn |
| Dec 31, 2021 | 27.10 Mn |
| Sep 30, 2021 | 52.10 Mn |